Figure 6

Combination of MyD88 and p-Akt provides better prognostic value for HCC. (a) The expression of MyD88 and the phosphorylation levels of p-Akt in hepatoma cell lines were compared by western blot assay. (b) Representative view of immunohistochemical staining of MyD88 and p-Akt and statistical correlation between MyD88 expression and p-Akt levels are shown. Scale bar, 100 μm. (c, d) The overall and recurrence-free survival rates of HCC patients with high or low MyD88 and p-Akt levels were compared using Kaplan–Meier analysis